These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 38967485)

  • 1. Exploiting Matrix Stiffness to Overcome Drug Resistance.
    Aydin HB; Ozcelikkale A; Acar A
    ACS Biomater Sci Eng; 2024 Aug; 10(8):4682-4700. PubMed ID: 38967485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond matrix stiffness: targeting force-induced cancer drug resistance.
    Kalli M; Poskus MD; Stylianopoulos T; Zervantonakis IK
    Trends Cancer; 2023 Nov; 9(11):937-954. PubMed ID: 37558577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
    Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
    Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering Drug Resistance: Investigating the Emerging Role of Hyaluronan Metabolism and Signaling and Tumor Extracellular Matrix in Cancer Chemotherapy.
    Vitale DL; Parnigoni A; Viola M; Karousou E; Sevic I; Moretto P; Passi A; Alaniz L; Vigetti D
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting autophagy to overcome drug resistance: further developments.
    Chang H; Zou Z
    J Hematol Oncol; 2020 Nov; 13(1):159. PubMed ID: 33239065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and impact of altered tumour mechanics.
    Mohammadi H; Sahai E
    Nat Cell Biol; 2018 Jul; 20(7):766-774. PubMed ID: 29950570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
    Singh A; Brito I; Lammerding J
    Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting autophagy to overcome drug resistance in cancer therapy.
    Kumar A; Singh UK; Chaudhary A
    Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanotransduction pathways in regulating epithelial-mesenchymal plasticity.
    Horta CA; Doan K; Yang J
    Curr Opin Cell Biol; 2023 Dec; 85():102245. PubMed ID: 37804773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of epithelial-mesenchymal transition in cancer drug resistance.
    Shang Y; Cai X; Fan D
    Curr Cancer Drug Targets; 2013 Nov; 13(9):915-29. PubMed ID: 24168191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity.
    Shen YW; Zhou YD; Chen HZ; Luan X; Zhang WD
    Trends Cancer; 2021 Jun; 7(6):511-524. PubMed ID: 33358571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition.
    Wei SC; Yang J
    Trends Cell Biol; 2016 Feb; 26(2):111-120. PubMed ID: 26508691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
    Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
    Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of epithelial-mesenchymal transition-regulating transcription factors in anti-cancer drug resistance.
    Seo J; Ha J; Kang E; Cho S
    Arch Pharm Res; 2021 Mar; 44(3):281-292. PubMed ID: 33768509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate Stiffness Drives Epithelial to Mesenchymal Transition and Proliferation through the
    Xu X; Zhang Y; Wang X; Li S; Tang L
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.
    Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM
    Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV4 regulates matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition.
    Sharma S; Goswami R; Zhang DX; Rahaman SO
    J Cell Mol Med; 2019 Feb; 23(2):761-774. PubMed ID: 30450767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.